Arkolith/Insider Trading/AGLE/Form 4

Burrows Scott L

Chief Financial OfficerAeglea BioTherapeutics, Inc. (AGLE) · full profile →Form 4 · filed Sep 5, 2023
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
1
0 non-derivative · 1 derivative

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Sep 1, 2023Grant(A)10.1M—$010.1M

Transaction Codes

A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000950170-23-046384) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML